Please assess the completion status of the following clinical trial:

Trial Title: Cerebral Prophylactic Irradiation With Saving Hippocampus and Amygdala

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients over 18 years of age~* Patients with a limited SCLC demonstrated histologically responsive or stable to radiochemotherapy or patients with a histologically proven extended SCLC responding to chemotherapy.~* WHO Performance Index 0-1 and / or Karnovsky Index\> 70~* Possibility of long-term monitoring~Exclusion Criteria:~* Concomitant chemotherapy~* Impossibility of performing an MRI or CT without injection~* Presence of cerebral metastases~* History of cerebral irradiation at any time~* Patient suffering from severe collagenosis~* Patient with cognitive disorders with MMSE score \<24

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Irradiation prophyllactique cérébrale (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).